| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.04. | Neola Medical AB: Neola Medical Reports Positive Safety Results from First Clinical Pilot Study and Advances Towards Next Phase of Clinical Development | 84 | GlobeNewswire (Europe) | Neola Medical today announces final results from its clinical pilot study, confirming a favorable safety profile of Neola® across the studied patient population, including very low birth weight preterm... ► Artikel lesen | |
| 16.03. | Neola Medical AB: Neola Medical Completes Enrollment in Swedish Clinical Pilot Study | 208 | GlobeNewswire (Europe) | Neola Medical announces completion of patient enrollment in its clinical pilot study on preterm born babies in Sweden. All ten babies have now been included in the study, marking an important milestone... ► Artikel lesen | |
| 12.02. | Neola Medical: Strategischer Fokus auf klinische Validierung und US-Markteintritt im Q4 2025 Earnings Call | 1 | Investing.com Deutsch | ||
| 12.02. | Neola Medical AB: Neola Medical Q4 Report 2025 - Advancing IP Protection as a Core Strategic Asset across Key Markets | 126 | GlobeNewswire (Europe) | During the quarter four new patents were granted, adding in total of seven new patent grants during 2025. This marks Neola Medical's strongest year to date in terms of IP protection across all key target... ► Artikel lesen | |
| 02.12.25 | Neola Medical AB: Neola Medical granted U.S. patent for disposable probes, strengthening future revenue model in target market | 177 | GlobeNewswire (Europe) | Neola Medical AB (publ) announces today that the company has been granted a U.S. patent protecting its disposable probes for the medical device Neola®. The advanced light and detector probes are used... ► Artikel lesen | |
| 13.11.25 | Neola Medical AB: Neola Medical granted Patent in China for reducing optical noise in lung monitoring measurements | 186 | GlobeNewswire (Europe) | Neola Medical AB (publ) has been granted its first patent in China for a technical solution that reduces noise in measurements for continuous lung monitoring. The patent protects an innovation designed... ► Artikel lesen | |
| NEOLA MEDICAL Aktie jetzt für 0€ handeln | |||||
| 04.11.25 | Neola Medical AB: Revised Timeline Announced as Clinical Pilot Study Indicates Robust Safety and Need for Optimization of Neola | 151 | GlobeNewswire (Europe) | Preliminary results from Neola Medical's ongoing clinical pilot study on preterm born babies indicate a robust safety profile of the medical device Neola®.
The preliminary findings indicate variations... ► Artikel lesen | |
| 04.11.25 | Neola Medical AB: Neola Medical Q3 Report 2025 - Progressing toward completion of Swedish clinical pilot study and strengthening leadership team | 114 | GlobeNewswire (Europe) | During the quarter Neola Medical strengthened the leadership team with appointment of a Clinical Director. In addition, the company's IP portfolio was reinforced in Europe with a newly granted patent... ► Artikel lesen | |
| 16.10.25 | Neola Medical AB: Neola Medical Strengthens Global IP Portfolio with New Patents Granted in both the U.S. and China for Medical Device Neola | 182 | GlobeNewswire (Europe) | Neola Medical AB (publ) has been granted patents in both the U.S. and China for a technical method that improve the accuracy of continuous lung monitoring with the company's medical device, Neola®.... ► Artikel lesen | |
| 25.09.25 | Neola Medical AB: Neola Medical strengthens leadership team with appointment of Clinical Director | 228 | GlobeNewswire (Europe) | Neola Medical AB (publ) is pleased to announce the appointment of Eva Bondesson as Clinical Director, effective October 1, 2025. As Neola Medical advances through the clinical phase, Eva Bondesson brings... ► Artikel lesen | |
| 10.09.25 | Neola Medical AB: Neola Medical granted European patent enabling lung monitoring beyond preterm born babies | 173 | GlobeNewswire (Europe) | Neola Medical AB (publ) announces today that the company has been granted a European patent for an invention aiming to enable lung monitoring in broader patient groups. This new patent complements the... ► Artikel lesen | |
| 25.08.25 | Neola Medical AB: Neola Medical Q2 Report 2025 - First U.S. Clinical Study Site Agreement Signed, Key Step in Regulatory Path to Market Authorization | 186 | GlobeNewswire (Europe) | Neola Medical advanced its U.S. regulatory pathway in the second quarter of 2025, signing an agreement with Children's Regional Hospital at Cooper and securing IRB approval to enable the initiation... ► Artikel lesen | |
| 21.05.25 | Neola Medical AB: Neola Medical Q1 Report 2025 - Strengthened shareholder base with institutional investors ahead of clinical study start | 271 | GlobeNewswire (Europe) | The first quarter of 2025 was both strategically and clinically significant for Neola Medical. The company strengthened its financial position through a successful directed share issue of approximately... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 39,520 | -0,90 % | Börse am Morgen: AMD, Fresenius, Infineon, Renk, Konjunkturdaten - Nord/LB | Die Erzeugerpreise in der Industrie im Euroraum sind mit Beginn des Nahost-Krieges deutlich gestiegen. Im März kletterten sie um 3,4% zum Vormonat. Allein die Energiepreise in der Industrie zogen im... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 33,900 | +0,98 % | Siemens Healthineers: Aktie rutscht nach enttäuschenden Zahlen ab - Anleger reagieren enttäuscht | Schwache Quartalszahlen und anhaltende Probleme in China setzen Siemens Healthineers weiter unter Druck. Die Aktie verliert deutlich, während der Medizintechnikkonzern seine Prognose für das laufende... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,660 | +1,05 % | Neue Märkte, erfolgreiche Restrukturierung und Abverkauf - dynaCERT Inc., Fresenius Medical Care, SMA Solar | Die globalen Märkte reagierten gestern sehr dynamisch auf Trumps Pause vom "Project Freedom". Der US-Präsident beendet vorläufig die US-Militärmission zur Begleitung von Handelsschiffen durch die Straße... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 28,720 | +12,36 % | Carl Zeiss Meditec unter Druck: Jetzt beginnt der harte Umbau beim MedTech-Konzern | Carl Zeiss Meditec wird es ernst: Nach schwachen Halbjahreszahlen zieht das Management nun die Reißleine und startet eines der größten Effizienzprogramme der Unternehmensgeschichte. Bis zu 1.000 Stellen... ► Artikel lesen | |
| WORK MEDICAL TECHNOLOGY GROUP | 7,330 | +10,06 % | WORK Medical Technology Group LTD: WORK Medical Collaborates with Novabioplus to Unlock Biological Data Value with AI, Advancing the "BioToken" Assetization Model | ||
| GERRESHEIMER | 28,400 | +1,21 % | Aktionär Active Ownership erhöht Gerresheimer-Aktienbeteiligung leicht | DJ Aktionär Active Ownership erhöht Gerresheimer-Aktienbeteiligung leicht
DOW JONES--Der Luxemburger Investor Active Ownership hat seine Beteiligung bei Gerresheimer leicht aufgestockt. Wie aus... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 18,370 | -0,05 % | S&P Dow Jones Indices: Alignment Healthcare Set to Join S&P SmallCap 600 | NEW YORK, May 11, 2026 /PRNewswire/ -- Alignment Healthcare Inc. (NASD: ALHC) will replace Sun Country Airlines Holdings Inc. (NASD: SNCY) in the S&P SmallCap 600... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 55,48 | -0,04 % | Recent Price Trend in BrightSpring Health Services, Inc. (BTSG) is Your Friend, Here's Why | ||
| HIMS & HERS HEALTH | 21,380 | +0,28 % | Earnings Preview: Nebius, Hims & Hers, Cisco & Co. Welche Zahlen diese Woche spannend werden! | © Foto: Yuki Iwamura - AP/dpa +++ dpa-Bildfunk +++Diese in den kommenden Tagen (KW20) anstehenden US-Quartalszahlen müssen Anlegerinnen und Anleger kennen: Herausforderungen, Erwartungen und die aktuell... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 28,730 | +0,14 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 7,940 | +0,13 % | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen | |
| PACS GROUP | 41,030 | 0,00 % | Full Transcript: PACS Group Q1 2026 Earnings Call | ||
| PROGYNY | 23,460 | +0,04 % | 3 Highly Ranked Medical Stocks to Buy Now: DVA, GMED, PGNY | ||
| BILLIONTOONE | 94,85 | +0,66 % | BillionToOne mit Gewinnsprung in Q1 2026: Aktie steigt nach starken Zahlen deutlich | ||
| UNITEDHEALTH | 338,40 | +0,18 % | Here's What Analysts Are Saying About UnitedHealth Group (UNH) |